Literature DB >> 11790661

Increased macrophage inflammatory protein-1alpha and macrophage inflammatory protein-1beta levels in bronchoalveolar lavage fluid of patients affected by different stages of pulmonary sarcoidosis.

Armando Capelli1, Antonino Di Stefano, Mirco Lusuardi, Isabelle Gnemmi, Claudio F Donner.   

Abstract

Macrophage inflammatory protein (MIP)-1alpha and MIP-1beta are two CC chemokines that induce lymphocyte migration. MIP-1alpha preferentially mediates chemotaxis of CD8 rather than CD4 lymphocytes, whereas the reverse is true for MIP-1beta. Both these chemokines recognize CCR5 as a cellular receptor in T lymphocytes and alveolar macrophages. We measured the concentrations of MIP-1alpha and MIP-1beta in bronchoalveolar lavage fluid (BALF) of 30 subjects affected by different stages of pulmonary sarcoidosis and 18 healthy normal subjects. We also evaluated the expression of CCR5 in alveolar macrophages and lymphocytes. The BALF concentrations of MIP-1alpha were significantly increased only in Stage II and III sarcoidosis. On the contrary, the concentrations of MIP-1beta were significantly increased at all stages. A striking increase of CCR5 expression was observed in both lymphocytes and macrophages of all patients, along with a trend to decreased positivity from Stage I to III of the disease. The MIP-1beta concentrations correlated with the number of total (r = 0.65, p = 0.0001) and both CD4 (r = 0.64, p = 0.0001) and CD8 (r = 0.62, p = 0.0001) lymphocytes; on the contrary, the MIP-1alpha concentrations correlated only with CD8 lymphocytes (r = 0.45, p = 0.002). Finally, significant negative correlations were observed between the neutrophil percentage and CCR5 expression in alveolar macrophages (r = -0.53, p = 0.005) and lymphocytes (r = -0.43, p = 0.01). Our results help to explain the mechanism of CD4 and CD8 recruitment and the possible involvement of CC chemokines in the fibrotic progression of sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11790661     DOI: 10.1164/ajrccm.165.2.2106084

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  16 in total

1.  Polymorphisms in chemokine and chemokine receptor genes and the development of coal workers' pneumoconiosis.

Authors:  Rachel Nadif; Margaret Mintz; Selma Rivas-Fuentes; Anne Jedlicka; Elise Lavergne; Mathieu Rodero; Francine Kauffmann; Christophe Combadière; Steven R Kleeberger
Journal:  Cytokine       Date:  2006-02-07       Impact factor: 3.861

2.  Steroid-sparing effects of pentoxifylline in pulmonary sarcoidosis.

Authors:  M K Park; H Babaali; L I Gilbert-McClain; M Stylianou; J Joo; J Moss; V C Manganiello
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2009-07       Impact factor: 0.670

3.  Inflammatory profile and response to anti-tumor necrosis factor therapy in patients with chronic pulmonary sarcoidosis.

Authors:  Matthew J Loza; Carrie Brodmerkel; Roland M Du Bois; Marc A Judson; Ulrich Costabel; Marjolein Drent; Mani Kavuru; Susan Flavin; Kim Hung Lo; Elliot S Barnathan; Robert P Baughman
Journal:  Clin Vaccine Immunol       Date:  2011-04-20

4.  Relationship between radiologic patterns, pulmonary function values and bronchoalveolar lavage fluid cells in newly diagnosed sarcoidosis.

Authors:  Regina Aleksonienė; Ingrida Zeleckienė; Mindaugas Matačiūnas; Roma Puronaitė; Laimutė Jurgauskienė; Radvilė Malickaitė; Edita Strumilienė; Vygantas Gruslys; Rolandas Zablockis; Edvardas Danila
Journal:  J Thorac Dis       Date:  2017-01       Impact factor: 2.895

5.  Giant cell formation in sarcoidosis: cell fusion or proliferation with non-division?

Authors:  T C M Th van Maarsseveen; W Vos; P J van Diest
Journal:  Clin Exp Immunol       Date:  2008-12-05       Impact factor: 4.330

6.  Different activity of the biological axis VEGF-Flt-1 (fms-like tyrosine kinase 1) and CXC chemokines between pulmonary sarcoidosis and idiopathic pulmonary fibrosis: a bronchoalveolar lavage study.

Authors:  Katerina M Antoniou; Giannoula Soufla; Athanasia Proklou; George Margaritopoulos; Christiana Choulaki; Rena Lymbouridou; Katerina D Samara; Demetrios A Spandidos; Nikolaos M Siafakas
Journal:  Clin Dev Immunol       Date:  2010-02-14

7.  CC chemokine receptor 5 gene polymorphisms in beryllium disease.

Authors:  H Sato; L Silveira; P Spagnolo; M Gillespie; E B Gottschall; K I Welsh; R M du Bois; L S Newman; L A Maier
Journal:  Eur Respir J       Date:  2010-01-14       Impact factor: 16.671

8.  CXCL9 and 11 in patients with pulmonary sarcoidosis: a role of alveolar macrophages.

Authors:  Y Nishioka; K Manabe; J Kishi; W Wang; M Inayama; M Azuma; S Sone
Journal:  Clin Exp Immunol       Date:  2007-06-05       Impact factor: 4.330

9.  Female-specific association of C-C chemokine receptor 5 gene polymorphisms with Löfgren's syndrome.

Authors:  Annegret Fischer; Ruta Valentonyte; Almut Nebel; Michael Nothnagel; Joachim Müller-Quernheim; Manfred Schürmann; Stefan Schreiber
Journal:  J Mol Med (Berl)       Date:  2008-03-01       Impact factor: 4.599

10.  BAL fluid cells in newly diagnosed pulmonary sarcoidosis with different clinical activity.

Authors:  Edvardas Danila; Laimute Jurgauskiene; Jolita Norkuniene; Radvile Malickaite
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.